No profile data available.
Relmada Therapeutics, Inc. (RLMD) is a healthcare company in the brain and nerve treatment drugs industry, based in Coral Gables, United States, with about 17 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of -$57.39 million. Its market capitalization was $361.61 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company in the United States.
Relmada Therapeutics reported $0 in revenue for fiscal year 2025.
$361.61 million as of October 9, 2026.
Listed companies of a similar size in the same industry (brain and nerve treatment drugs) include Ovid Therapeutics Inc. (OVID), Capricor Therapeutics, Inc. (CAPR), Prothena Corporation plc (PRTA), Benitec Biopharma Inc. (BNTC).